Background and Purpose: Early noncontrast computed tomographic scans may visualize a hyperdense middle cerebral artery before the infarct becomes visible. This sign disappears within a few days, corresponds to the clot itself, and might be associated with a poor prognosis. The aim of the study was to determine its prevalence, diagnostic value, relationship to demographic data, ability to separate embolic from nonembolic causes, short-term prognostic value, evolution over time, and relationship to arterial occlusion on angiography.
arly computed tomographic (CT) demonstration of infarction in the territory of the middle cerebral artery (MCA) is of diagnostic value, but the hypodense area usually occurs several hours after the onset of symptoms. 1 Before the infarct becomes visible, noncontrast early CT scans may visualize a hyperdense MCA 2 -' 4 sign, which disappears within a few days ; the diagnostic value and the relationship of this sign to demographic data have not been assessed, and the prognostic value of this sign has not been clearly established. Most reports underline the poor prognosis in patients with this sign, 7913 but they have not taken into account other important prognostic factors or demographic data.
We performed this study on the hyperdense MCA sign to determine its prevalence, diagnostic value, relationship to demographic data, ability to separate embolic from nonembolic causes, short-term prognostic value, evolution over time, and relationship to MCA occlusion on angiography.
Subjects and Methods
We conducted our study over a 12-month period (February 1, 1990-January 31, 1991) on 443 patients admitted for a first acute cerebrovascular event whose final diagnosis was either cerebral infarct or nontraumatic intracerebral hemorrhage or transient ischemic attack. One hundred seventy-one patients had at least one exclusion criteria ( Table 1) . The remaining 272 patients consisted of 132 men and 140 women of mean age 67.36 (range 15-96) years. Forty-nine patients had a transient ischemic attack, defined as an episode of focal cerebral dysfunction lasting <24 hours and followed by return to normality; 223 had a stroke, defined as clinical signs of focal disturbance of cerebral function lasting >24 hours or leading to death with no apparent cause other than of vascular origin. All patients were free of toxic and metabolic disorders involving the glia and of any history suggesting multiple sclerosis or leukodystrophy. We isolated a subgroup of 151 patients with MCA infarct: their first CT scan was normal, and they had either an infarct (including lacunes) relevant to the clinical deficits within the MCA area on a second CT scan or clinical data suggestive of an involvement of the MCA territory, but no abnormality on the second CT scan. This subgroup of patients consisted of 75 men and 76 women of mean age 66.61 (range 15-96) years, 35 with a transient ischemic attack and 116 with stroke.
We prospectively collected the following data: age, clinical presentation (either transient ischemic attack or stroke, as defined above); level of consciousness accord- ing to the 0-3-point subtest of the Modified National Institute of Health Stroke Scale 15 ; intensity of the neurological deficit, using a 0-100-point rating scale 16 ; presence of hypertension (Inzitari's criteria 17 ), diabetes mellitus and cardiovascular disorders (Leys' criteria 18 ), elevated blood triglycerides (fasting serum level >2.5 g/1), elevated blood cholesterol (fasting serum level >2.5 g/1), coagulopathy (prothrombin time <85% or platelet count <50,000/mm 3 or any current anticoagulation); and cerebrovascular malformation, determined only in patients who underwent angiography or autopsy.
In all patients we performed a noncontrast CT scan within 12 hours after onset on a Siemens Somatom II machine (Siemens, FRG) using 5-mm contiguous slice thickness in a plane 15° negative to the canthomeathal plane. Scan time was 9.6 seconds per slice. A second CT scan was performed during days 10-15 using the same technique, except when the first CT scan revealed hemorrhagic lesion. One of us performed the assessment of the hyperdense MCA sign on the first CT scan before the assessment of focal vascular lesions was performed on a subsequent CT. Hyperdense MCA sign was defined as present when the patients fulfilled five criteria: 1) spontaneous visibility of the whole horizontal part of the MCA, 2) density of the MCA higher than that of the surrounding brain, 3) disappearance on bone windows, 4) unilaterality, and 5) absence of subarachnoid bleeding. The same observer assessed focal lesions on the second CT scan except in patients with hemorrhagic hemispheric strokes. This observer determined whether the following lesions were present: cortical infarct (any infarct including the cortical surface), deep infarct (infarct >2 cm sparing the cortical surface), lacune (deep infarct <2 cm within the basal ganglia or the periventricular areas), brain stem infarct, cerebellar infarct, cortical hemorrhage (hemorrhage including the cortical surface), and deep hemorrhage (hemorrhage including the basal ganglia or the internal capsule or both and sparing the cortical surface). Patients with hemorrhagic changes within an infarct were quoted as infarcts. MCA infarcts were divided into four subtypes according to the presumed cause ( Table 2 ). The second observer, blinded to the clinical data, assessed leukoaraiosis and cerebral atrophy from the first CT scan. We defined leukoaraiosis using Inzitari's criteria. 17 The observer measured independently extension and severity of leukoaraiosis, using the 0-3-point Blennow's rating scale 19 in which 0 means absence of leukoaraiosis. The observer also assessed cerebral atrophy from the first CT scan using a semiquantitative 0-3-point rating scale highly correlated to linear measures that takes into account ventricular and sulcal enlargement, 20 in which 0 means absence of cerebral atrophy. Leukoaraiosis and cerebral atrophy were assessed on the hemisphere opposite to the focal vascular lesion or on the right hemisphere in patients without focal lesion.
We determined the outcome at days 14-16 in the MCA infarct subgroup as death; persistence of neurological symptoms or signs, whatever the intensity; or total recovery. All patients received a 10-day course of oral nimodipine (90-120 mg daily) and subcutaneous nadroparine, a low-molecular-weight heparinoid (7,500-30,000 units daily). The four patients who received oral or intravenous nicardipine (up to 150 mg daily) did not receive nimodipine. Other treatments have sometimes been prescribed for hypertension or intercurrent diseases, but the patients were not given neuroeffectors or vasodilatator drugs. Five patients treated with early thrombolytic therapy were excluded from the outcome analysis because the indication of thrombolysis had not been randomized.
We analyzed the results to define the prevalence of the hyperdense MCA sign in the whole group of patients with an acute stroke and in the MCA infarct subgroup; the sensitivity, the specificity, the predictive value of a positive sign, the predictive value of a negative sign, and the likelihood ratio 21 ; relationship to age, cerebral atrophy, and leukoaraiosis scores; association with risk factors; the ability to differentiate embolic from nonembolic causes; and the short-term prognostic value of the hyperdense MCA. In a second step of analysis, we performed a multiple linear regression using the occurrence of either death or total recovery as dependent variables (0, absent; 1, present) and 16 independent (or explanatory) variables. Using Fisher's exact test, we compared the rate of hemorrhagic changes on the second CT scan between patients with the hyperdense MCA sign and patients without. The evolution of the hyperdense MCA sign over time was assessed, and the relationship between the hyperdense MCA sign and MCA occlusion was studied on angiography performed within 1 hour after the first CT scan in patients eligible for intra-arterial thrombolysis. Statistics were performed using a 0.01 level of significance.
Results We obtained CT scans within 3 hours in 25 patients, within 6 hours in 51 other patients, within 9 hours in 88 other patients, and within 12 hours in the remaining 108 patients. We found 73 patients with the hyperdense MCA sign, resulting in a prevalence of 26.8% in the whole group, 30.5% in the MCA infarct subgroup, and 41.2% in patients with MCA infarcts seen on the second CT scan. The hyperdense MCA sign was homolateral to the clinically involved hemisphere in all patients. The breakdown of patients with the sign according to the type of focal lesions is reported in Table 3 . Because some patients had had silent infarcts, multiple infarcts appeared on their CT scans. Within the whole group, patients with the hyperdense MCA sign were more likely to have nonhemor- cardiac aneurysm, cardiomyopathy, congenital heart disease, rheumatic heart disease, endocarditis, atrial fibrillation, atrial myxoma, sick sinus syndrome, atrial septal defect with evidence of a deep artery thrombosis.
Unknown cause Applied to any patient who did not fulfill criteria for any of the above causes.
rhagic strokes, cortical infarcts, and deep infarcts >2 cm. In the MCA infarct subgroup, patients with the hyperdense MCA sign were more likely to have a cortical infarct or a deep infarct >2 cm seen on the second CT scan. The hyperdense MCA sign has never been seen in patients with a single infarct located outside the MCA territory and relevant to the clinical deficits. Brain stem infarcts seen in 14 patients with the dense MCA sign and cerebellar infarcts seen in 10 were silent infarcts irrelevant to the deficits. The diagnostic value of the hyperdense MCA sign is reported in Table 4 . It revealed an excellent specificity for the diagnosis of MCA infarct but a moderate sensitivity. We found no relationship between the presence of a dense MCA sign and demographic data, cerebral atrophy, leukoaraiosis, and mechanisms of infarction, but patients with this sign were more likely to have more persistent deficits and less likely to have total recovery (Table 5 ). The sign provided a gain of 3.51% in predicting death (pretest probability 1.37%; posttest probability 4.88%) and a gain of 19.53% in predicting bad outcome, either death or partial recovery (pretest probability 60.96%; posttest probability 80.49%). However, 19.51% of patients with a hyperdense MCA sign totally recovered within 2 weeks. In the 146 patients with MCA infarcts who did not undergo a thrombolysis, 12 had hemorrhagic changes on their second CT scan, without any clinical worsening; four of these had a hyperdense MCA sign, whereas eight did not (/?=0.60). The multiple linear regression analysis did not identify the hyperdense MCA sign as an independent factor of death (p=0.416) or total recovery (/?=0.8225). In 70 of the 73 patients, the hyperdense MCA sign had disappeared on the second CT scan. The remaining three patients died within 5 days; the hyperdense MCA sign had disappeared on the second CT scan performed at days 2 and 4 in two patients, but was still present at day 2 in one patient. An early angiography was performed in the 11 patients admitted within 3 hours after onset, who were eligible for thrombolysis. The five patients who had a hyperdense MCA sign had an occlusion of the trunk of the MCA; in four a recanalization was obtained after a selective intra-arterial administration of 60-120 mg recombinant tissue plasminogen activator. In these four patients, the hyperdense MCA sign disappeared on a CT scan performed within 12 hours after the procedure. In one patient treated by intra-arterial recombinant tissue plasminogen activator, the hyperdense MCA sign almost disappeared at the end of the procedure (Figure 1 ). except in patients with hemorrhages whose diagnosis was obvious on the first scan. Except with hemorrhages, knowing the type of focal lesion appears unlikely to produce a bias when assessing the hyperdense MCA sign, especially in patients in the MCA infarct group whose first CT scan was normal. Recruitment bias was also unlikely because we studied consecutive patients admitted as emergency cases with acute stroke and excluded patients referred from other hospitals. We presume for several reasons that the increased density of the MCA that we found in 73 patients represents an occlusion of the MCA by a clot. In all cases, the increased density remained throughout the course of the MCA, then disappeared within a few days in all patients except one, who had an early death. All patients who underwent angiography had occlusion of the MCA corresponding to the CT findings; moreover, this sign disappeared soon after recanalization in one patient. No patient had evidence of subintimal hemorrhage, although this could only be excluded in patients who underwent angiography.
Discussion
11 Misinterpretation between hyperdense MCA sign and calcified emboli 22>23 or calcified intracranial arteries 24 was excluded because the hyperdensity disappeared on bone windows and on the second CT scan; moreover, MCA calcifications would probably have been bilateral. A normal artery surrounded by a lucent structure may stand out as a higher density 2 ; however, misinterpretation of an isodense MCA within the hypodensity of a surrounding infarct is unlikely because the MCA sign was observed before any focal infarct in most patients and in all patients in the MCA infarct group. Previous studies have not taken into account the relationship of the hyperdense MCA sign to cerebral atrophy and leukoaraiosis.
2 - 14 Misinterpretation of an isodense MCA surrounded by cerebrospinal fluid in widened subarachnoidal spaces or by leukoaraiosis is also unlikely because patients with hyperdense MCA sign had the same degree of cerebral atrophy and leukoaraiosis as patients without.
We found a higher prevalence of the hyperdense MCA sign than in previous studies except that of Bastianello et al, which provided a 50% prevalence of the sign.
14 His findings might be explained by the early Odds ratios of the presence of a hyperdense middle cerebral artery (MCA) sign in patients according to demographic data, presumed causes of computed tomographic focal lesions, and outcome at day 14-16. *99% confidence intervals (CI).
inclusion (within 4 hours) and the use of slice thickness from 2 to 4 mm. 14 The hyperdense MCA sign might have been underestimated in studies using 10-mm slice thickness as previously suggested by Pressman et al. 5 Reduction of the slice thickness improves the detectability of a clot within the MCA 5 -8 by reducing partial-volume effects that would make the appreciation of a hyperdense MCA difficult. Launes and Ketonen 7 reported 13 of 50 patients (26%) with MCA infarcts, but they might have missed some cases because inclusions were performed up to 24 hours after onset. Ricci et al 13 found the sign in 15.6% of patients in a retrospective study of 90 patients with supratentorial infarcts included within 12 hours. Pressman et al 5 found a 2.54% prevalence in patients with strokes of any type and location, and Tomsick et al 9 found a 20.6% prevalence in patients with MCA infarcts. Thus, the prevalence of the hyperdense MCA sign depends mainly on the delay between first symptoms and CT scan and the slice thickness.
The hyperdense MCA sign is specific for nonhemorrhagic strokes; it has never been seen in hemorrhagic strokes. A bias cannot be excluded because hemorrhages might have hidden a hyperdense MCA, and the observer was not actually blinded to the diagnosis when he assessed the presence of the hyperdense MCA sign.
Relationships between the hyperdense MCA sign, demographic data, cerebrovascular risk factors and the type of focal lesions, and the mechanism of MCA infarcts have not been taken into account in previous studies.
-
14 Giroud et al 12 suggested a relationship between the hyperdense MCA sign and hypertension, vomiting, headache, and hyperglycemia; however, this might be more a relationship between the hyperdense MCA sign and predictors of a poor outcome. Bogousslavsky et al 2526 found that 30% of the MCA territory infarcts were small and limited to the lenticulocapsular area, indicating that 30% of so-called lacunar infarcts may be due to large-vessel disease. We found that patients with the hyperdense MCA sign were more likely to have nonhemorrhagic strokes, cortical infarcts, and deep infarcts >2 cm, but were less likely to have lacunes, brain stem or cerebellar infarcts, or normal CT scan. This suggests that visualization of the hyperdense MCA sign is a good predictor of large MCA infarcts, but not of lacunar infarcts. Emboli might be the main cause of acute occlusion of the MCA; the autopsy of 31 patients with MCA occlusion 27 revealed only two patients with atherosclerotic occlusive thrombosis of the MCA, whereas the 29 remaining patients had embolic occlusion from the proximal internal carotid artery or from the heart. Pressman et al 5 suggested a lack of specificity of the hyperdense MCA sign with regard to the mechanism of stroke. Our study supports this opinion.
Most case reports have underlined the poor prognosis in patients with the sign. - 8 In the study of Tomsick et al, 9 the hyperdense MCA sign was related to the volume of the infarct on CT scan. In that of Launes and Ketonen, 7 10 of the 13 patients with the sign died within 1 month, and only one had a good outcome, results suggesting that the hyperdense MCA sign might be a useful predictor of poor outcome. According to Ricci et al, 13 patients with the sign were more likely to have a worse outcome than patients without. However, these studies 7 -13 did not take into account other important prognostic factors. Contrary to Ricci et al, 13 we included a larger number of patients and did not select them with regard to stroke severity. This explains the lower rate of early death in our study group and our inability to conclude anything about the predictive value of death using the hyperdense MCA sign. The prognosis of an MCA occlusion is not always poor. 28 Bogousslavsky et al 25 showed that patients with an MCA occlusion have a 7.1% annual rate of cerebral infarct and a 2.6% annual rate of death, and that only 15% of survivors are severely handicapped 4 years later. The multiple linear regression analysis did not identify this sign as an independent factor of death or total recovery, and one fifth of patients with this sign had an excellent prognosis. Our study on the hyperdense MCA sign is, to our knowledge, the first in which the analysis of outcome has taken into account prognostic factors and in which all patients have had similar treatment. This might explain the differences between our findings and those of previous studies. Tomsick et al 9 suggested that the hyperdense MCA sign might be a valuable predictor of hemorrhagic changes, an opinion confirmed by Bastianello et al. 14 In our study the number of hemorrhagic changes was too small to allow any conclusion on this point.
The hyperdense MCA sign corresponds to the clot itself. Drayer et al 29 MCA occlusion has always been visualized, as in our study. The hyperdense MCA sign usually occurs very early in the time-course of MCA occlusions, 2 -14 except in one patient with a normal early CT scan and a hyperdense MCA sign 5 days later. 2 Middle cerebral artery occlusion is often a transient phenomenon, as suggested by serial angiographies, 30 -31 probably due to an early fragmentation of the embolus by spontaneous thrombolysis leading to an early recanalization in some patients. Our five patients treated with thrombolysis demonstrate the early disappearance of the sign after removal of the clot. In the study of Bastianello et al, 14 each time the occlusion of the MCA disappeared, the sign also disappeared.
We conclude that recognition of the hyperdense MCA sign can be very valuable in the CT diagnosis of infarction within 12 hours, but does not always predict a poor outcome.
